We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Another online supplement distributor has earned the FDA’s ire for selling weight-loss supplements that contain undisclosed prescription ingredients and potentially carcinogenic ingredients. Read More
EMA is proposing a broader scope for guidelines on initial human trials to address emergent practices and safety issues linked to participant deaths. Read More
The FDA approved eight ANDAs for AstraZeneca’s blockbuster cholesterol drug Crestor after a federal judge denied the company’s bid to stave off the approvals. Read More
The UK’s drug pricing watchdog is recommending reimbursement of PTC Therapeutics’ Translarna to treat Duchenne muscular dystrophy, provided the company complies with an access agreement. Read More